Related Experiment Video
Updated: Sep 6, 2026

An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
Published on: September 13, 2016
Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets
Jeongtae Kim1, Jiyoon Chun2, Meejung Ahn3
1Department of Anatomy, Kosin University College of Medicine, Busan, Korea.
Abstract:
Experimental autoimmune uveitis (EAU), an animal model of human uveitis, is characterized by infiltration of autoimmune T cells in the uvea as well as in the retina of susceptible animals. EAU is induced by the immunization of uveitogenic antigens, including either retinal soluble-antigen or interphotoreceptor retinoid-binding proteins, in Lewis rats. The pathogenesis of EAU in rats involves the proliferation of autoimmune T cells in peripheral lymphoid tissues and breakdown of the blood-retinal barrier, primarily in the uvea and retina, finally inducing visual dysfunction. In this review, we describe recent EAU studies to facilitate the design of a therapeutic strategy through the interruption of uveitogenic factors during the course of EAU, which will be helpful for controlling human uveitis.
Related Concept Videos
Glaucoma: Overview
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...

